文献速递造血干细胞移植与细胞治疗

实验性移植物抗宿主病中胸腺固有淋巴样细胞缺失导致胸腺生成受损

Loss of thymic innate lymphoid cells leads to impaired thymopoiesis in experimental graft-versus-host disease.
PubMed 文献 · Blood · 2017-06-12

该研究在小鼠模型中证实,移植物抗宿主病(GVHD)导致胸腺3型固有淋巴样细胞(ILC3)耗竭,进而使胸腺内白细胞介素-22(IL-22)缺乏,抑制IL-22对胸腺上皮细胞(TEC)的保护并损害胸腺生成恢复;阻断供者T细胞IL-21受体信号或抑制胸腺ILC消除可改善胸腺生成,外源性IL-22给药可促进胸腺生成恢复及新胸腺来源外周T细胞发育。

要点

  • GVHD小鼠模型中胸腺ILC3耗竭,胸腺内IL-22较无GVHD移植受者缺乏。
  • IL-22缺乏抑制其对胸腺上皮细胞的保护,损害胸腺生成恢复。
  • 外源性IL-22给药可增加胸腺生成恢复及新胸腺来源外周T细胞发育。

核心结论

  • GVHD导致胸腺ILC3耗竭及胸腺内IL-22缺乏,从而损害胸腺生成恢复。
  • 恢复IL-22信号可改善GVHD相关胸腺生成障碍,外源性IL-22给药可增加胸腺生成恢复及新胸腺来源外周T细胞发育。
  • ILC-IL-22-TEC轴可能有助于增强临床造血移植后的免疫重建。

研究设计与样本

  • 实验性小鼠模型研究,比较GVHD组与无GVHD移植受者的胸腺ILC3及IL-22水平。

主要发现

  • GVHD导致胸腺ILC3耗竭,胸腺内IL-22较无GVHD移植受者缺乏。
  • 阻断供者T细胞IL-21受体信号并抑制胸腺ILC消除,以IL-22依赖方式改善胸腺生成。
  • 外源性IL-22给药后胸腺生成恢复增加、新胸腺来源外周T细胞发育增加,尽管同种反应性未被抑制。

临床怎么用

  • 作者认为,调控ILC-IL-22-TEC轴可能有助于增强临床造血移植后的免疫重建及其他T细胞缺陷情形。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Graft-versus-host disease (GVHD) and posttransplant immunodeficiency are frequently related complications of allogeneic hematopoietic transplantation. Alloreactive donor T cells can damage thymic epithelium, thus limiting new T-cell development. Although the thymus has a remarkable capacity to regenerate after injury, endogenous thymic regeneration is impaired in GVHD. The mechanisms leading to this regenerative failure are largely unknown. Here we demonstrate in experimental mouse models that GVHD results in depletion of intrathymic group 3 innate lymphoid cells (ILC3s) necessary for thymic regeneration. Loss of thymic ILC3s resulted in deficiency of intrathymic interleukin-22 (IL-22) compared with transplant recipients without GVHD, thereby inhibiting IL-22-mediated protection of thymic epithelial cells (TECs) and impairing recovery of thymopoiesis. Conversely, abrogating IL-21 receptor signaling in donor T cells and inhibiting the elimination of thymic ILCs improved thymopoiesis in an IL-22-dependent fashion. We found that the thymopoietic impairment in GVHD associated with loss of ILCs could be improved by restoration of IL-22 signaling. Despite uninhibited alloreactivity, exogenous IL-22 administration posttransplant resulted in increased recovery of thymopoiesis and development of new thymus-derived peripheral T cells. Our study highlights the role of innate immune function in thymic regeneration and restoration of adaptive immunity posttransplant. Manipulation of the ILC-IL-22-TEC axis may be useful for augmenting immune reconstitution after clinical hematopoietic transplantation and other settings of T-cell deficiency.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Dudakov JA, Mertelsmann AM, O'Connor MH, et al. Loss of thymic innate lymphoid cells leads to impaired thymopoiesis in experimental graft-versus-host disease. Blood. 2017. PMID: 28607133. doi:10.1182/blood-2017-01-762658

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。